Dosing Darbepoetin Alfa: Impact on Dialysis Patients

Examining the influence of intravenous darbepoetin alfa injection timing on dialysis-associated parameters

A 12-month, prospective, single-center cross-over study assessed the impact of the time of IV darbepoetin alfa injection during dialysis on Hb level, ESA dosing and other parameters.¹

Reliable Effectiveness of Darbepoetin Alfa Throughout Dialysis Treatment

The Dosage of Darbepoetin Remains Unaffected by Timing of Injection

Timing of Darbepoetin Alfa Injection Has No Influence on Nutritional Status

Dialysis with Darbepoetin Alfa: Its Distinctive Attributes

Abbreviations: ▼

CKD: Chronic kidney disease; EPO: Erythropoietin; Hb: Hemoglobin.

References:▼

1. Rottembourg J, Kpade F, Dansaert A, et al. Timing of the administration of intravenous darbepoetin alfa during the dialysis session: Does it impact efficacy? Dailysis & Transplantation. 2009;38(12):493–499. 2. Khullar D, Muchhala S S, T A. Advancing anemia management in chronic kidney disease: Assessing the superiority of darbepoetin alfa over erythropoietin alpha. Cureus. 2024;16(1):e51613.

LMRC Code: GGI-CO-A1-AQS-DCVN-BANNERS-A24-0530

Cresp 1

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Know more

Dosing Darbepoetin Alfa: Impact on Dialysis Patients

Dosing Darbepoetin Alfa: Impact on Dialysis Patients, Cresp, Nephrology, Nephrologist, Dialysis, CKD, Darbepoetin alfa, Anemia, Hematology, Haematologist

Related Articles

Login to continue